Its pathophysiology involves peripheral insulin resistance, dysregulated hepatic glucose production, and progressive β-cell dysfunction, ultimately leading to β-cell destruction and the consequent loss of insulin secretory capacity [21,22]. This evidence concerns the gene INS and Insulin resistance.